Business Practice

We find out how technology is enabling remote inspections in the pharma industry.

Reconfigure. Redefine. Why modular cleanroom furniture is essential for a changing pharmaceutical market.

That which we call rosaimab by any other name would find regulatory approval and commercial success. Or would it?

An industry consortium is tackling one of pharma’s biggest drug-related challenges.

Sitting Down With Dolores Schendel, Chief Executive Officer and Chief Scientific Officer at Medigene.

IFPMA’s Director-General, Thomas Cueni, outlines how companies worldwide can foster long-term tech transfer partnerships.

It’s time for pharma companies to embrace digital technologies.

The Russian invasion of Ukraine will disrupt and displace a great deal of work in drug discovery. Here’s why.

We talk to Roche’s Paulo Fontoura about Evrysdi and its impact on patient lives.

In this new series, we ask industry leaders in the cell and gene field to answer key questions about the industry.